Efficacy of continuous venovenous hemodiafiltration combined with hemoperfusion in the treatment of acute kidney injury and its influence on levels of serum nerve guidance factor-1 and kidney injury factor-1
10.3760/cma.j.cn115455-20240419-00347
- VernacularTitle:连续性血液透析滤过联合血液灌流治疗急性肾损伤的疗效及对血清神经导向因子-1、肾损伤因子-1水平的影响
- Author:
Xiaoxia GAO
1
;
Min ZHAO
;
Yuying YANG
;
Jiming LI
Author Information
1. 新疆医科大学第一附属医院急救创伤中心，乌鲁木齐 830000
- Keywords:
Acute kidney injury;
Hemodiafiltration;
Hemoperfusion;
Nerve guidance factor-1;
Renal injury factor-1
- From:
Chinese Journal of Postgraduates of Medicine
2024;47(12):1081-1085
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the efficacy of continuous venovenous hemodiafiltration (CVVHDF) combined with hemoperfusion in the treatment of acute kidney injury (AKI) and its influence on the levels of serum nerve guidance factor-1 (Netrin-1) and kidney injury factor-1 (Kim-1).Methods:A total of 193 patients with AKI diagnosed and treated in the First Affiliated Hospital of Xinjiang Medical University from January 2018 to January 2021 were prospectively selected and divided into the control group (96 cases) and the observation group (97 cases) according to random number table method. The control group was given conventional treatment, and the observation group was given CVVHDF combined with hemopirrigation on the basis of conventional treatment. The levels of Netrin-1, Kim-1, renal function index, critical disease score and inflammatory response index before and after treatment were compared between the two groups.Results:After 72 h of treatment, the serum levels of Netrin-1, Kim-1, creatinine and urea nitrogen in the observation group were lower than those in the control group: (5.43 ± 0.61)ng/L vs. (7.52 ± 0.83) ng/L, (0.97 ± 0.23) ng/L vs. (1.52 ± 0.29) ng/L, (97.58 ± 8.51) μmol/L vs. (109.80 ± 7.56) μmol/L, (5.72 ± 1.19) mmol/L vs. (7.40 ± 1.75) mmol/L, there were statistical differences ( P<0.05). After 72 h of treatment, the scores of acute physiology and chronic health evaluation Ⅱ and multiple organ dysfunction syndrome in the observation group were lower than those in the control group: (14.26 ± 5.62) scores vs. (16.82 ± 3.75) scores, (7.15 ± 0.86) scores vs. (8.23 ± 0.92) scores, there were statistical differences ( P<0.05). After 72 h of treatment, the levels of tumor necrosis factor-α, interleukin-6 and C-reactive protein in the observation group were lower than those in the control group: (13.26 ± 4.06) ng/L vs. (29.30 ± 5.81) ng/L, (14.56 ± 3.29) ng/L vs. (29.88 ± 5.40) ng/L, (12.06 ± 3.43) mg/L vs. (33.82 ± 4.94) mg/L, there were statistical differences ( P<0.05). Conclusions:CVVHDF combined with hemoperfusion can effectively improve the renal function of patients with AKI, reduce the levels of serum inflammatory factors, alleviate the disease and promote recovery.
